Innovation
Accelerated


Data Driven Discovery

Innovation drives antibody discovery. We deliver elusive antibodies in a short period of time, with high probability of succeeding to clinical trials.


Company

Our multi-national team has the experience and expertise to accelerate your project.


COVID-19

Our subsidiary Talem Therapeutics has developed a rich and diverse discovery portfolio of SARS-CoV-2 candidate antibodies yielding epitope and functional diversity.